Connect with us

INDUSTRIAL HEMP

AURORA CANNABIS IN (OTCMKTS:ACBFF) Executes Lock-up Deals With 38% Of CanniMed Shareholders

Published

on

AURORA CANNABIS IN (OTCMKTS:ACBFF) has submitted a plan to acquire all of the outstanding and issued common shares of CanniMed Therapeutics Inc. Pertaining to the proposal, the company has entered into irrevocable lock-up deals in support of its plan from shareholders representing around 38% of CanniMed’s outstanding shares.

As per the lock-up deals, the locked-up shareholders are prohibited from voting or tendering any of their CanniMed common shares in favor of any other acquisition proposal pertaining to CanniMed and are needed to vote against other deal proposals or measures which might delay, prevent or frustrate Aurora’s plan.

The details

Aurora considers the value that would come from the combination of the two firms is considerable. Together, their complementary and unique strengths would lead value, establish the leading cannabis firm across several markets, and the combined entity will reduce production costs while linking consumers through market major brands.

Among other things, the new firm will have combined total active registered cannabis patients of more than 40,000 in Canada; have notable grow capacity with five advanced facilities, and additional facilities deliberated; and have funded or existing capacity of more than 130,000 kilograms of yearly production with substantial additional capacity planned.

This deal will further strengthen both firms’ global presence with agreements and operations in the European Union, the Cayman Islands and Australia. It will increase the capacity to service and reach a wider global patient base with an extensive product offering; enhance yields through cross-application of exclusive technologies from each of CanniMed and Aurora.

The deal will offer CanniMed with access to company’s network of strategic associates, such as extraction technology pioneer Radient Technologies. It will allow CanniMed to use Aurora’s segment leadership in innovation to support development and expand both firms’ portfolio of genetics. Also, CanniMed can leverage Aurora’s unmatched e-commerce platform, including the sole mobile app in Canada that allows customer purchases.


 

 

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Symbol        Alert        High        Gain

 

  VBIO          $0.67       $4.10      500%

  IMLFF        $0.11       $0.57      400%

  CMXC        $0.25       $0.45      80%

  REPCF       $0.54       $0.79      48%

 

Get Your Latest Winner Delivered to Your Inbox!

FREE

For The Next 48 Hours

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement